XML 45 R30.htm IDEA: XBRL DOCUMENT
v3.21.1

Earnings Per Share (Tables) | 9 Months Ended
--- | ---
Apr. 03, 2021
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Net (Loss) Income Per Share | The following table sets forth the computation of basic and diluted net income per share (in millions, except per share data):
| Three Months Ended |  | Nine Months Ended
| April 3, 2021 |  | March 28, 2020 |  | April 3, 2021 |  | March 28, 2020
Numerator: |  |  |  |  |  |  |
Net income (loss) | $ | 11.8 |  |  | $ | (32.8) |  |  | $ | 48.0 |  |  | $ | 2.0 |
Denominator: |  |  |  |  |  |  |
Weighted-average shares outstanding: |  |  |  |  |  |  |
Basic | 228.7 |  |  | 230.0 |  |  | 228.8 |  |  | 229.8 |
Shares issuable assuming conversion of convertible notes (1) | 8.5 |  |  | — |  |  | 2.3 |  |  | 3.0 |
Effect of dilutive securities from stock-based compensation plans | 3.0 |  |  | — |  |  | 2.7 |  |  | 3.5 |
Diluted | 240.2 |  |  | 230.0 |  |  | 233.8 |  |  | 236.3 |
Net income (loss) per share: |  |  |  |  |  |  |
Basic | $ | 0.05 |  |  | $ | (0.14) |  |  | $ | 0.21 |  |  | $ | 0.01 |
Diluted | $ | 0.05 |  |  | $ | (0.14) |  |  | $ | 0.21 |  |  | $ | 0.01 |
(1) Represents the number of shares that would be issued if the Company’s 1.00% Senior Convertible Notes (2024 Notes) and 1.75% Senior Convertible Notes (2023 Notes) had been converted. The par amount of the Company’s convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest. The “in-the money” conversion benefit feature above the conversion price of the 2023 Notes and 2024 Notes of, $13.94 and $13.22 per share, respectively is payable in cash, shares of the Company’s common stock or a combination of both, at the Company’s election. Refer to “Note 11. Debt” for more details.
Schedule of Weighted Average Potentially Dilutive Securities Excluded from the Computation Because Their Effect Would Have Been Anti-dilutive | The following table sets forth the weighted-average potentially dilutive securities excluded from the computation of the diluted net income per share because their effect would have been anti-dilutive (in millions):
| Three Months Ended |  | Nine Months Ended
| April 3, 2021 |  | March 28, 2020 |  | April 3, 2021 |  | March 28, 2020
|  |  | (1) (2) |  |  |  |
Restricted stock units | 0.3 |  |  | 7.3 |  |  | 0.4 |  |  | 0.2 |
Stock options and ESPP | — |  |  | 1.2 |  |  | — |  |  | — |
Shares issuable from Convertible Notes | — |  |  | 1.3 |  |  | — |  |  | — |
Total potentially dilutive securities | 0.3 |  |  | 9.8 |  |  | 0.4 |  |  | 0.2 |
(1) As the Company incurred a loss from continuing operations in the period, potential securities from employee stock options, ESPP, restricted stock units (RSUs) and performance stock units (PSUs) have been excluded from the dilutive net loss per share computations as their effects were deemed anti-dilutive. (2) The Company’s 1.75% Senior Convertible Notes due 2023 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the money” conversion benefit feature at the conversion price above $13.94 per share is payable in cash, shares of the Company’s common stock or a combination of both, at the Company’s election. The Company’s average stock price for the period presented did not exceed the conversion price of $13.94. Refer to “Note 11. Debt” for more details.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration